{"id":"https://openalex.org/W2013662056","doi":"https://doi.org/10.1097/00002826-200001000-00012","title":"Intravenous Administration of Levodopa Ameliorated a Refractory Akathisia Case Induced by Interferon-Alpha","display_name":"Intravenous Administration of Levodopa Ameliorated a Refractory Akathisia Case Induced by Interferon-Alpha","alternate_titles":[],"publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2013662056","doi":"https://doi.org/10.1097/00002826-200001000-00012","mag":"2013662056","pmid":"https://pubmed.ncbi.nlm.nih.gov/10682234"},"language":"en","primary_location":{"id":"doi:10.1097/00002826-200001000-00012","doi":"https://doi.org/10.1097/00002826-200001000-00012","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002826-200001000-00012","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013662056"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056209359","display_name":"Makoto Sunami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126247","display_name":"Nishikawa Hospital","ror":"https://ror.org/032qsa580","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210126247"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Makoto Sunami","raw_affiliation_strings":["Department of Psychiatry, Seiwakai Nishikawa Hospital, Hamada, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Seiwakai Nishikawa Hospital, Hamada, Japan","institution_ids":["https://openalex.org/I4210126247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108728329","display_name":"Tadashi Nishikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126247","display_name":"Nishikawa Hospital","ror":"https://ror.org/032qsa580","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210126247"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tadashi Nishikawa","raw_affiliation_strings":["Department of Psychiatry, Seiwakai Nishikawa Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Seiwakai Nishikawa Hospital","institution_ids":["https://openalex.org/I4210126247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003105609","display_name":"Akio Yorogi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akio Yorogi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110003792","display_name":"Masaru Shimoda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masaru Shimoda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5056209359","https://openalex.org/A5108728329"],"corresponding_institution_ids":["https://openalex.org/I4210126247"],"apc_list":null,"apc_paid":null,"fwci":0.8478,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.71620619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"23","issue":"1","first_page":"59","last_page":"61"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.2727000117301941,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.2727000117301941,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.21040000021457672,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12569","display_name":"Restless Legs Syndrome Research","score":0.10530000180006027,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.8019999861717224},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.890999972820282},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9340000152587891},{"id":"https://openalex.org/keywords/drug-induced-movement-disorders","display_name":"drug-induced movement disorders","score":0.7289999723434448},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.7429999709129333},{"id":"https://openalex.org/keywords/levomepromazine","display_name":"levomepromazine","score":0.7110000252723694},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.7139999866485596},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C2777374534","wikidata":"https://www.wikidata.org/wiki/Q409761","display_name":"Amantadine","level":2,"score":0.8285388946533203},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.8000438213348389},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7800565958023071},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.6627190709114075},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5921210646629333},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5080006718635559},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.49691155552864075},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4928031265735626},{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.46510276198387146},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.44604790210723877},{"id":"https://openalex.org/C2780656706","wikidata":"https://www.wikidata.org/wiki/Q417204","display_name":"Levomepromazine","level":4,"score":0.41449376940727234},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32855406403541565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28384479880332947},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.23595374822616577},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.20116233825683594},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.18338105082511902},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.12478604912757874},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.10235276818275452},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.09072673320770264},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0665276050567627},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.0},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.0},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002826-200001000-00012","doi":"https://doi.org/10.1097/00002826-200001000-00012","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002826-200001000-00012","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:10682234","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10682234","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1534046497","https://openalex.org/W1975508030","https://openalex.org/W1982050481","https://openalex.org/W2018732717","https://openalex.org/W2029738096","https://openalex.org/W2060024172","https://openalex.org/W2077601302","https://openalex.org/W2087704532","https://openalex.org/W2093896551","https://openalex.org/W2095344219","https://openalex.org/W2103889259","https://openalex.org/W2108861328","https://openalex.org/W2414465783"],"related_works":["https://openalex.org/W2409325625","https://openalex.org/W166484287","https://openalex.org/W2031301125","https://openalex.org/W1983856503","https://openalex.org/W190716775","https://openalex.org/W1982050481","https://openalex.org/W2026466939","https://openalex.org/W2036668243","https://openalex.org/W1822200793","https://openalex.org/W2118792812"],"abstract_inverted_index":{"A":[0],"28":[1,20],"year-old":[2],"man":[3],"with":[4,124],"chronic":[5],"hepatitis":[6],"B":[7],"was":[8],"administered":[9],"interferon-alpha":[10,106],"(5":[11],"x":[12],"10(6)":[13],"IU)":[14],"intramuscularly":[15],"once":[16],"a":[17,71,99],"day":[18],"for":[19,38,73],"days.":[21,75],"Eight":[22],"days":[23],"after":[24,91,105],"the":[25,121],"end":[26],"of":[27,33,64,93,102],"interferon":[28],"treatment,":[29],"he":[30],"showed":[31],"signs":[32],"inability":[34],"to":[35,70],"sit":[36],"still":[37],"ten":[39],"seconds":[40],"and":[41,54,108,116],"walked":[42],"around":[43],"constantly.":[44],"His":[45],"akathisia":[46,82,104],"symptoms":[47,83],"worsened":[48],"thereafter.":[49],"Clonazepam,":[50],"thioridazine,":[51],"beta-blockers,":[52],"anticholinergics,":[53],"bromocriptine":[55],"did":[56],"not":[57],"ameliorate":[58],"his":[59,81],"akathisia.":[60],"Two":[61],"days'":[62],"administration":[63,92],"levomepromazine":[65],"100":[66],"mg":[67,79],"led":[68],"him":[69],"coma":[72],"2":[74,89],"Intravenous":[76],"levodopa":[77,111],"25":[78],"ameliorated":[80],"drastically.":[84],"He":[85],"became":[86],"completely":[87],"premorbid":[88],"weeks":[90],"levodopa.":[94],"The":[95],"present":[96],"report":[97],"illustrates":[98],"rare":[100],"case":[101],"refractory":[103],"treatment":[107,112],"also":[109],"that":[110],"would":[113],"be":[114],"theoretically":[115],"practically":[117],"useful":[118],"in":[119],"reducing":[120],"neurotoxicity":[122],"associated":[123],"interferon-alpha.":[125]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2013662056","counts_by_year":[{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
